The chemical class of ACOT6 Inhibitors is characterized by a range of compounds that interact with various metabolic pathways to indirectly modulate the activity of ACOT6. These molecules are not necessarily direct antagonists of the enzyme's active site but rather influence the concentration of substrates or the metabolic context in which ACOT6 functions. By altering levels of fatty acyl-CoAs through the inhibition or modulation of other enzymes in lipid metabolism, these inhibitors indirectly reduce the substrate availability for ACOT6, which can lead to decreased enzymatic activity.
The influence of these inhibitors extends beyond a single target; they have broader effects on cellular metabolism. For example, compounds that inhibit enzymes responsible for synthesizing fatty acids or acyl-CoAs can reduce the pool of these molecules within the cell, thereby affecting the balance between free fatty acids and their CoA esters. This balance is crucial for various cellular processes, including energy production and lipid biosynthesis. Therefore, many of the indirect inhibitors of ACOT6 play a role in redirecting metabolic fluxes and can have an impact on the regulation of energy homeostasis and lipid metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $187.00 $843.00 | 14 | |
Inhibits long-chain acyl-CoA synthetase, decreasing the acyl-CoA substrate availability for ACOT6. | ||||||
rac Perhexiline Maleate | 6724-53-4 | sc-460183 | 10 mg | $188.00 | ||
Inhibits carnitine palmitoyltransferase-1, which may decrease fatty acyl-CoA levels, indirectly affecting ACOT6 activity. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $151.00 $506.00 | 3 | |
Inhibits carnitine palmitoyltransferase-1 and could lead to reduced fatty acyl-CoA levels for ACOT6 hydrolysis. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Uncouples oxidative phosphorylation, altering acyl-CoA metabolism and ACOT6 activity. | ||||||
TOFA (5-(Tetradecyloxy)-2-furoic acid) | 54857-86-2 | sc-200653 sc-200653A | 10 mg 50 mg | $97.00 $374.00 | 15 | |
Inhibits acetyl-CoA carboxylase, reducing malonyl-CoA levels and affecting ACOT6-related metabolic pathways. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Inhibits fatty acid synthase, decreasing fatty acyl-CoA levels and indirectly affecting ACOT6 activity. | ||||||
C75 (racemic) | 191282-48-1 | sc-202511 sc-202511A sc-202511B | 1 mg 5 mg 10 mg | $72.00 $206.00 $290.00 | 9 | |
Inhibits fatty acid synthase and could lead to reduced fatty acyl-CoA levels for ACOT6. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
Inhibits HMG-CoA reductase, which may influence fatty acid synthesis pathways and indirectly affect ACOT6. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, which can inhibit acetyl-CoA carboxylase, affecting fatty acyl-CoA levels for ACOT6. | ||||||
4-Hydroxy-L-phenylglycine | 32462-30-9 | sc-254680A sc-254680 | 5 g 10 g | $82.00 $109.00 | ||
Inhibits carnitine palmitoyltransferase-1, reducing the availability of fatty acyl-CoA for ACOT6. | ||||||